Naloxone, the opioid overdose-reversing medication commonly known by its brand name Narcan, was central to the response of ...

A major drug investigation in Crawford County resulted in the seizure of a large quantity of illegal drugs, including ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Florida’s importation program hasn’t brought in a single Canadian drug. It’s not cost-effective and it could be dangerous.

US supplement maker Robinson Pharma has unveiled new global distribution partnerships to safeguard brand quality and consumer ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

A growing disconnect remains between what generics are approved and what are actually accessible, GoodRx said.

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...